April 27th, 2011 → 12:24 pm
// No Comments
Publishers Weekly Review of Ockham’s Razor:
A timely theme and superb narrative pacing make this tale of corporate skullduggery a satisfyingly suspenseful read. One ordinary Thursday morning Dagney Hamilton, an executive with Infinitec Pharmaceuticals, is told by the company president to relinquish all documentation on Epiproxen, an anti-obesity drug whose development Dagney has overseen for five years. In exchange, Dagney is promoted to a VP position and cut a bonus check for a cool million—both bribes for keeping her lips zipped about the drug. When the company’s president and lead research scientist both die under suspicious circumstances shortly thereafter, Dagney realizes that merciless and determined people are taking extraordinary risks to suppress all data concerning Epiproxen. After two failed attempts on her own life, Dagney goes underground and, with the help of crusty cop Mark Stone, begins unraveling the snarled threads of a conspiracy that reaches beyond Infinitec to political lobbyists for the fast-food industry, and possibly to the White House itself. Though the science in this story is a little shaky,] and dispensed in clunky, if accessible, chunks of exposition, the writer handles it skillfully enough to suspend reader disbelief. The characters are all familiar types whose personalities are well developed, if not well reasoned (Dagney is a retired cop, whose turn to the pharmaceutical industry is never explained). This is a fairly formulaic thriller, but the writer has a solid grasp of storytelling mechanics and, through deft use of cross-cutting, short staccato chapters, and well-timed surprises, the pages keep turning.
Tags: Publishers weekly